Prostate cancer: Clinical practice guidelines in oncology™

James Mohler, Robert R. Bahnson, Barry Boston, J. Erik Busby, Anthony D'Amico, James A. Eastham, Charles A. Enke, Daniel George, Eric Mark Horwitz, Robert P. Huben, Philip Kantoff, Mark Kawachi, Michael Kuettel, Paul H. Lange, Gary MacVicar, Elizabeth R. Plimack, Julio M. Pow-Sang, Mack Roach, Eric Rohren, Bruce J. RothDennis C. Shrieve, Matthew R. Smith, Sandy Srinivas, Przemyslaw Twardowski, Patrick Walsh

Research output: Contribution to journalArticle

Abstract

The intention of these guidelines is to provide a framework on which to base treatment decisions. Prostate cancer is a complex disease, with many controversial aspects of management and a dearth of sound data to support treatment recommendations. Several variables (including life expectancy, disease characteristics, predicted outcomes, and patient preferences) must be considered by patients and physicians when tailoring prostate cancer therapy to the individual patient.

Original languageEnglish (US)
Pages (from-to)162-200
Number of pages39
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume8
Issue number2
StatePublished - Feb 2010
Externally publishedYes

Fingerprint

Practice Guidelines
Prostatic Neoplasms
Patient Preference
Life Expectancy
Therapeutics
Guidelines
Physicians

Keywords

  • Active surveillance
  • Early detection
  • Life expectancy estimation
  • NCCN clinical practice guidelines
  • Prostate cancer
  • Prostate-specific antigen
  • Radiation therapy
  • Radical prostatectomy
  • Screening

ASJC Scopus subject areas

  • Oncology

Cite this

Mohler, J., Bahnson, R. R., Boston, B., Busby, J. E., D'Amico, A., Eastham, J. A., ... Walsh, P. (2010). Prostate cancer: Clinical practice guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network, 8(2), 162-200.

Prostate cancer : Clinical practice guidelines in oncology™. / Mohler, James; Bahnson, Robert R.; Boston, Barry; Busby, J. Erik; D'Amico, Anthony; Eastham, James A.; Enke, Charles A.; George, Daniel; Horwitz, Eric Mark; Huben, Robert P.; Kantoff, Philip; Kawachi, Mark; Kuettel, Michael; Lange, Paul H.; MacVicar, Gary; Plimack, Elizabeth R.; Pow-Sang, Julio M.; Roach, Mack; Rohren, Eric; Roth, Bruce J.; Shrieve, Dennis C.; Smith, Matthew R.; Srinivas, Sandy; Twardowski, Przemyslaw; Walsh, Patrick.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 8, No. 2, 02.2010, p. 162-200.

Research output: Contribution to journalArticle

Mohler, J, Bahnson, RR, Boston, B, Busby, JE, D'Amico, A, Eastham, JA, Enke, CA, George, D, Horwitz, EM, Huben, RP, Kantoff, P, Kawachi, M, Kuettel, M, Lange, PH, MacVicar, G, Plimack, ER, Pow-Sang, JM, Roach, M, Rohren, E, Roth, BJ, Shrieve, DC, Smith, MR, Srinivas, S, Twardowski, P & Walsh, P 2010, 'Prostate cancer: Clinical practice guidelines in oncology™', JNCCN Journal of the National Comprehensive Cancer Network, vol. 8, no. 2, pp. 162-200.
Mohler J, Bahnson RR, Boston B, Busby JE, D'Amico A, Eastham JA et al. Prostate cancer: Clinical practice guidelines in oncology™. JNCCN Journal of the National Comprehensive Cancer Network. 2010 Feb;8(2):162-200.
Mohler, James ; Bahnson, Robert R. ; Boston, Barry ; Busby, J. Erik ; D'Amico, Anthony ; Eastham, James A. ; Enke, Charles A. ; George, Daniel ; Horwitz, Eric Mark ; Huben, Robert P. ; Kantoff, Philip ; Kawachi, Mark ; Kuettel, Michael ; Lange, Paul H. ; MacVicar, Gary ; Plimack, Elizabeth R. ; Pow-Sang, Julio M. ; Roach, Mack ; Rohren, Eric ; Roth, Bruce J. ; Shrieve, Dennis C. ; Smith, Matthew R. ; Srinivas, Sandy ; Twardowski, Przemyslaw ; Walsh, Patrick. / Prostate cancer : Clinical practice guidelines in oncology™. In: JNCCN Journal of the National Comprehensive Cancer Network. 2010 ; Vol. 8, No. 2. pp. 162-200.
@article{7ea47a93ff2944a381f61d3d676dc70f,
title = "Prostate cancer: Clinical practice guidelines in oncology™",
abstract = "The intention of these guidelines is to provide a framework on which to base treatment decisions. Prostate cancer is a complex disease, with many controversial aspects of management and a dearth of sound data to support treatment recommendations. Several variables (including life expectancy, disease characteristics, predicted outcomes, and patient preferences) must be considered by patients and physicians when tailoring prostate cancer therapy to the individual patient.",
keywords = "Active surveillance, Early detection, Life expectancy estimation, NCCN clinical practice guidelines, Prostate cancer, Prostate-specific antigen, Radiation therapy, Radical prostatectomy, Screening",
author = "James Mohler and Bahnson, {Robert R.} and Barry Boston and Busby, {J. Erik} and Anthony D'Amico and Eastham, {James A.} and Enke, {Charles A.} and Daniel George and Horwitz, {Eric Mark} and Huben, {Robert P.} and Philip Kantoff and Mark Kawachi and Michael Kuettel and Lange, {Paul H.} and Gary MacVicar and Plimack, {Elizabeth R.} and Pow-Sang, {Julio M.} and Mack Roach and Eric Rohren and Roth, {Bruce J.} and Shrieve, {Dennis C.} and Smith, {Matthew R.} and Sandy Srinivas and Przemyslaw Twardowski and Patrick Walsh",
year = "2010",
month = "2",
language = "English (US)",
volume = "8",
pages = "162--200",
journal = "Journal of the National Comprehensive Cancer Network : JNCCN",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "2",

}

TY - JOUR

T1 - Prostate cancer

T2 - Clinical practice guidelines in oncology™

AU - Mohler, James

AU - Bahnson, Robert R.

AU - Boston, Barry

AU - Busby, J. Erik

AU - D'Amico, Anthony

AU - Eastham, James A.

AU - Enke, Charles A.

AU - George, Daniel

AU - Horwitz, Eric Mark

AU - Huben, Robert P.

AU - Kantoff, Philip

AU - Kawachi, Mark

AU - Kuettel, Michael

AU - Lange, Paul H.

AU - MacVicar, Gary

AU - Plimack, Elizabeth R.

AU - Pow-Sang, Julio M.

AU - Roach, Mack

AU - Rohren, Eric

AU - Roth, Bruce J.

AU - Shrieve, Dennis C.

AU - Smith, Matthew R.

AU - Srinivas, Sandy

AU - Twardowski, Przemyslaw

AU - Walsh, Patrick

PY - 2010/2

Y1 - 2010/2

N2 - The intention of these guidelines is to provide a framework on which to base treatment decisions. Prostate cancer is a complex disease, with many controversial aspects of management and a dearth of sound data to support treatment recommendations. Several variables (including life expectancy, disease characteristics, predicted outcomes, and patient preferences) must be considered by patients and physicians when tailoring prostate cancer therapy to the individual patient.

AB - The intention of these guidelines is to provide a framework on which to base treatment decisions. Prostate cancer is a complex disease, with many controversial aspects of management and a dearth of sound data to support treatment recommendations. Several variables (including life expectancy, disease characteristics, predicted outcomes, and patient preferences) must be considered by patients and physicians when tailoring prostate cancer therapy to the individual patient.

KW - Active surveillance

KW - Early detection

KW - Life expectancy estimation

KW - NCCN clinical practice guidelines

KW - Prostate cancer

KW - Prostate-specific antigen

KW - Radiation therapy

KW - Radical prostatectomy

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=77649158894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649158894&partnerID=8YFLogxK

M3 - Article

C2 - 20141676

AN - SCOPUS:77649158894

VL - 8

SP - 162

EP - 200

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

SN - 1540-1405

IS - 2

ER -